Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, tolerability, pharmacokinetics and pharmacodynamics of SLV337 in type 2 diabetes patients on metformin
2009-011589-27Phase 2Completed
- Sponsor
- Fournier
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SLV337 in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Fournier. Primary endpoints: Primary: Safety and tolerability of SLV337 and Primary: Pharmacokinetics of SLV337. Started Jul 2009; status: completed.
02
Drugs
SLV337
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-011589-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011589-27.